DBV Technologies
"DBV Technologies" is a trademark owned by DBV Technologies, filed at the WIPO on September 19, 2022. It is registered and covers classes 5, 10, 41, 42 and 44.
- Status
- Registered
- Filed
- September 19, 2022
- Registered
- Not yet
- Expires
- September 19, 2032
- Application no.
- Not recorded
- Registration no.
- 1717862
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 5 classes
Who owns DBV Technologies
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
DBV Technologies
Representative
Jennifer Sheehan Anderson
Bridge Intellectual Property Services PL
What the mark covers
The products and services DBV Technologies is filed for, grouped by Nice class.
Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical or medicated substances in dry form for humans and animals for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases.
Medical apparatus, instruments and devices, namely, epicutaneous patches sold without medication for the cutaneous or epicutaneous administration of medicated or cosmetic substances in dry form for humans or animals; occlusion patch dispensers for medical use; medical instruments using the electrostatic properties of biocompatible media, namely, epicutaneous patches sold without medication.
Educational services for consumers and professionals in the field of immunotherapy, namely, organizing classes, seminars, programs, conferences, congresses, workshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing periodicals, books, guides and databases in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website.
Medical and scientific research in the field of immunotherapy, namely, developing scientific methods for epicutaneous immunotherapy, to try to treat and prevent autoimmune, infectious and inflammatory diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; scientific research in the field of allergy treatment and care; scientific research in the field of allergy treatment for the repeated application of treatments to patients' skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact and thus avoid the passage of allergens into the blood; allergenic drug discovery services; medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and skin immune cells; medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' unbroken skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact.
Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of allergens, antigens using patches affixed to the patients' unbroken skin, thus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases using epicutaneous methods of desensitization via immunotherapy; epicutaneous medical treatments and prevention of allergies, inflammatory, autoimmune and infectious diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to allergies with respect to desensitization to combat allergies.
About DBV Technologies
Who owns the trademark "DBV Technologies"?
The WIPO trademark "DBV Technologies" is owned by DBV Technologies.
What is the status of "DBV Technologies"?
Its status at the WIPO is: registered.
Get this data via the API
Everything on this page comes from the Signa API. Pull DBV Technologies and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_a13f2a70-66e3-458e-8747-6e2a1b503332
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_a13f2a70-66e3-458e-8747-6e2a1b503332",
"object": "trademark",
"mark_text": "DBV Technologies",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2022-09-19",
"nice_classes": [
5,
10,
41,
42,
44
],
"owners": [
{
"name": "DBV TECHNOLOGIES",
"entity_id": "ent_019eb706-d4df-739e-ba1d-b3581088cd30"
}
]
}